全球领先疫苗，39支疫苗进入3期实验，10月13日，德国法国放弃两款mRNA疫苗，转为研发新一代疫苗和加强剂。中国两款疫苗进入第三期试验。
- 主题发起人 lindamy
- 开始时间
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness'
https://www.cnn.com/profiles/maggie-fox
By Maggie Fox, CNN
Updated 9:31 PM ET, Mon October 12, 2020
www.cnn.com
https://www.cnn.com/profiles/maggie-fox
By Maggie Fox, CNN
Updated 9:31 PM ET, Mon October 12, 2020
Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness' | CNN
Johnson&Johnson said its Janssen arm had paused its coronavirus vaccine trial after an "unexplained illness" in one of the volunteers testing its experimental Covid-19 shot.
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
5 min ago
Pfizer to start testing its vaccine in kids as young as 12
From CNN's Maggie Fox
Drugmaker Pfizer has plans to start testing its experimental coronavirus vaccine in children as young as 12, and parents have already expressed interest in enrolling their kids, the researcher leading the trial told CNN Tuesday.
It will be the first coronavirus vaccine trial to include children in the United States.
A team at Cincinnati Children's Hospital will begin vaccinating teenagers aged 16 and 17 this week, and will move to enroll 12-to 15-year-olds later, said Dr. Robert Frenck, director of the Vaccine Research Center at the hospital.
The company confirmed on its website it has approval from the US Food and Drug Administration to enroll children as young as 12 in its trial.
RELATED
Pfizer to start testing its Covid-19 vaccine in children as young as 12
Pfizer to start testing its vaccine in kids as young as 12
From CNN's Maggie Fox
Drugmaker Pfizer has plans to start testing its experimental coronavirus vaccine in children as young as 12, and parents have already expressed interest in enrolling their kids, the researcher leading the trial told CNN Tuesday.
It will be the first coronavirus vaccine trial to include children in the United States.
A team at Cincinnati Children's Hospital will begin vaccinating teenagers aged 16 and 17 this week, and will move to enroll 12-to 15-year-olds later, said Dr. Robert Frenck, director of the Vaccine Research Center at the hospital.
The company confirmed on its website it has approval from the US Food and Drug Administration to enroll children as young as 12 in its trial.
Read the full story:
RELATED
Pfizer to start testing its Covid-19 vaccine in children as young as 12
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
6 min ago
Study finds one Chinese Covid-19 vaccine is safe
From CNN's Leanna Faulk
A Covid-19 vaccine candidate being developed in China is “safe and well tolerated,” a new study published Thursday reports.
The vaccine, called BBIBP-CorV, is created by China's state-run pharmaceutical group Sinopharm. Its Phase 1/2 study, involving more than 600 volunteers, showed that they all developed an immune response and none had severe adverse reactions, the researchers reported in the journal The Lancet Infectious Diseases.
The trial was unable to determine how effective the vaccine is at preventing infection with the virus.
How the vaccine works: The vaccine uses one of the oldest and best-tested approaches to making vaccines -- inactivating or “killing” a virus and then using it to train the immune system.
This vaccine candidate is different from those being designed in the United States, which use pieces of genetic sequence of the coronavirus.
Study finds one Chinese Covid-19 vaccine is safe
From CNN's Leanna Faulk
A Covid-19 vaccine candidate being developed in China is “safe and well tolerated,” a new study published Thursday reports.
The vaccine, called BBIBP-CorV, is created by China's state-run pharmaceutical group Sinopharm. Its Phase 1/2 study, involving more than 600 volunteers, showed that they all developed an immune response and none had severe adverse reactions, the researchers reported in the journal The Lancet Infectious Diseases.
The trial was unable to determine how effective the vaccine is at preventing infection with the virus.
How the vaccine works: The vaccine uses one of the oldest and best-tested approaches to making vaccines -- inactivating or “killing” a virus and then using it to train the immune system.
This vaccine candidate is different from those being designed in the United States, which use pieces of genetic sequence of the coronavirus.
billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 15,318
- 荣誉分数
- 4,775
- 声望点数
- 373
还是传统灭活方法管用，但是成本较高，要先培养病毒。不知道为什么美国没有搞灭活病毒？可能太贵还是实验周期太长？据说RNA 疫苗直接跳过一期实验。不过也不能一颗树上吊死呀。我们单位搞研究也是几个组，每个都分别实验一种方法。
It is an inactivated vaccine, meaning it contains the virus but it has been grown in a laboratory and then killed, so it is not infectious.
Inactivated vaccines are well known and have been used against diseases such as influenza, measles and rabies. But they usually don't provide immunity that's as strong as live vaccines, so several doses over time may be necessary.
By Manas Mishra Reuters
Posted October 16, 2020 8:57 am
Coronavirus vaccine: Pfizer may ask for emergency approval in late November
Based on current trial enrollment and dosing in a late-stage trial, Pfizer expects to have that safety data in the third week of November, Chief Executive Officer Albert Bourla said in an open letter posted on the company’s website.
Posted October 16, 2020 8:57 am
Coronavirus vaccine: Pfizer may ask for emergency approval in late November
Based on current trial enrollment and dosing in a late-stage trial, Pfizer expects to have that safety data in the third week of November, Chief Executive Officer Albert Bourla said in an open letter posted on the company’s website.
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
In quest for vaccine, US makes 'big bet' on company with unproven technology
www.cnn.com
In quest for vaccine, US makes 'big bet' on company with unproven technology
The FDA green-lit Moderna's product for trial, making it the first vaccine candidate to advance to the first phase of a clinical study, in which an as-yet unapproved vaccine is injected into the arms of a small group of 45 human volunteers. Established in 2010, Moderna, has never brought a...
- 注册
- 2012-09-04
- 消息
- 62,964
- 荣誉分数
- 11,330
- 声望点数
- 1,373
In quest for vaccine, US makes 'big bet' on company with unproven technology
In quest for vaccine, US makes 'big bet' on company with unproven technology
The FDA green-lit Moderna's product for trial, making it the first vaccine candidate to advance to the first phase of a clinical study, in which an as-yet unapproved vaccine is injected into the arms of a small group of 45 human volunteers. Established in 2010, Moderna, has never brought a...
原来美国的疫苗公司只是泡泡。
嗯，川普喜欢就好。
哈哈
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
我是无意中看到这篇5月初写的文章，总统在bet ，现在还是出事了，NIH的头说按照现在的进展，很难在11月底之前批准疫苗。
Moderna股票4月底是46，现在是71，出事前更高。
Moderna's stock price has nearly doubled in the past 12 months
Shares in Moderna surged in February when news of its vaccine candidate emerged. They shot up again – by more than 24%, to $26.49 – on March 16, the day NIH announced the clinical trial of Moderna’s vaccine. The stock price jumped again on April 17 -- with news of the federal government’s nearly half-a-billion-dollar grant -- to beyond $45. Moderna shares closed at $46.37 on April 29.
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
1 hr 21 min ago
Canadian government will invest $214 million in Covid-19 vaccine development, Trudeau says
From Evan Simko-Bednarski
Canada's Prime Minister Justin Trudeau arriving at a press conference to discuss the COVID-19 pandemic in Ottawa, Ontario, on Tuesday, Oct. 13, 2020. Sean Kilpatrick/The Canadian Press/AP
Canadian Prime Minister Justin Trudeau pledged $214 million Friday toward efforts to develop a Covid-19 vaccine in the country.
Of that money, Trudeau said his administration is providing "up to $173 million" toward Quebec-based Medicago Inc.'s vaccine candidate, and their Quebec City-based factory.
Trudeau also announced $18.2 million for Vancouver-based Precision NanoSystems, and an additional $23 million towards various early-stage vaccine candidates.
The prime minister said the Canadian government had begun distributing hundreds of thousands of rapid Covid-19 tests to provincial governments.
The investment comes as Covid-19 cases in Canada are on the rise.
"Yesterday, Canada had the highest ever number of new cases of Covid-19," Trudeau said. "We have to get these numbers down. This is serious, and everybody must do their part."
Canadian government will invest $214 million in Covid-19 vaccine development, Trudeau says
From Evan Simko-Bednarski
Canada's Prime Minister Justin Trudeau arriving at a press conference to discuss the COVID-19 pandemic in Ottawa, Ontario, on Tuesday, Oct. 13, 2020. Sean Kilpatrick/The Canadian Press/AP
Canadian Prime Minister Justin Trudeau pledged $214 million Friday toward efforts to develop a Covid-19 vaccine in the country.
Of that money, Trudeau said his administration is providing "up to $173 million" toward Quebec-based Medicago Inc.'s vaccine candidate, and their Quebec City-based factory.
Trudeau also announced $18.2 million for Vancouver-based Precision NanoSystems, and an additional $23 million towards various early-stage vaccine candidates.
The prime minister said the Canadian government had begun distributing hundreds of thousands of rapid Covid-19 tests to provincial governments.
The investment comes as Covid-19 cases in Canada are on the rise.
"Yesterday, Canada had the highest ever number of new cases of Covid-19," Trudeau said. "We have to get these numbers down. This is serious, and everybody must do their part."
- 注册
- 2012-09-04
- 消息
- 62,964
- 荣誉分数
- 11,330
- 声望点数
- 1,373
1 hr 21 min ago
Canadian government will invest $214 million in Covid-19 vaccine development, Trudeau says
From Evan Simko-Bednarski
Canada's Prime Minister Justin Trudeau arriving at a press conference to discuss the COVID-19 pandemic in Ottawa, Ontario, on Tuesday, Oct. 13, 2020. Sean Kilpatrick/The Canadian Press/AP
Canadian Prime Minister Justin Trudeau pledged $214 million Friday toward efforts to develop a Covid-19 vaccine in the country.
Of that money, Trudeau said his administration is providing "up to $173 million" toward Quebec-based Medicago Inc.'s vaccine candidate, and their Quebec City-based factory.
Trudeau also announced $18.2 million for Vancouver-based Precision NanoSystems, and an additional $23 million towards various early-stage vaccine candidates.
The prime minister said the Canadian government had begun distributing hundreds of thousands of rapid Covid-19 tests to provincial governments.
The investment comes as Covid-19 cases in Canada are on the rise.
"Yesterday, Canada had the highest ever number of new cases of Covid-19," Trudeau said. "We have to get these numbers down. This is serious, and everybody must do their part."
现在才想起来投钱。
用这个钱去买其他国家经过检验证明效果可靠的疫苗不好吗？
不会又把钱给他家的关系户吧？
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
